Shivering. Complications of surgical and medical care, not elsewhere classified
Conditions
Interventions
Intervention 1: 8 mg dexamethasone IV. Intervention 2: 8 mg Ondanstrone IV. Intervention 3: 30 mg/kg Magnesium Sulfate IV.
Treatment - Drugs
8 mg dexamethasone IV
8 mg Ondanstrone IV
30 mg/kg Magnesium Sulfate IV
Sponsors
Golestan university of medical sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: age of 18 to 55 years; ASA1, 2; none shivering before surgery. Exclusion Criteria: Hypertension; allergies to medicines, ondasetrone, sufentanil, and magnesium sulfate; Drug addiction; cerebrovascular disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shivering. Timepoint: after surgery. Method of measurement: observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: after surgery. Method of measurement: VAS (Visual Analog Scale). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKazem Kazem nejad
anesthesiology Community
Outcome results
None listed